Total

(n = 496)

No exposure

(n = 455)

Exposure

(n = 41)

p

Median months to removal (IQR)

53 (28-90)

54 (28-91)

42 (22-78)

0.27

Median months follow-up (IQR)

19 (7-42)

19 (7-42)

12 (2-25)

0.0076

Median age at surgery (IQR)

58 (50-67)

58 (50-68)

54 (47-58)

0.0070

Race

Black

20 (4%)

18 (4%)

2 (5%)

0.84

Hispanic

33 (7%)

31 (7%)

2 (5%)

Other

6 (1%)

6 (1%)

0 (0%)

White

437 (88%)

400 (88%)

37 (90%)

Median Body Mass Index (IQR)

28 (24-32)

27.7 (24-31.4)

27 (24-32)

0.71

Obese

174 (36%)

160 (36%)

14 (34%)

0.85

Diabetes status

Non-diabetic

443 (89%)

408 (90%)

35 (85%)

0.58

Type 2 diabetes

13 (3%)

11 (2%)

2 (5%)

Insulin-dependent

40 (8%)

36 (8%)

4 (10%)

Median gravida (IQR)

2 (2-3)

2 (2-3)

3 (2-3.5)

0.18

Median parity (IQR)

2 (2-3)

2 (2-3)

2 (2-3)

0.66

Hormone replacement therapy (HRT)

76 (18%)

68 (18%)

8 (24%)

0.43

Menopausal status and HRT

Pre-menopausal

199 (45%)

178 (44%)

21 (55%)

0.31

Post-menopausal, no HRT

192 (43%)

180 (44%)

12 (32%)

Post-menopausal, on HRT

56 (13%)

51 (12%)

5 (13%)

Hysterectomy

376 (85%)

347 (85%)

29 (81%)

0.43

Smoking status

Ever smoker

186 (38%)

166 (36%)

20 (49%)

0.12

Never smoker

310 (63%)

289 (64%)

21 (51%)

Type of tape

Retropubic

269 (54%)

246 (54%)

23 (56%)

0.11

Obturator

137 (28%)

126 (28%)

11 (27%)

Mini sling

22 (4%)

20 (4%)

2 (5%)

Multiple slings

27 (5%)

22 (5%)

5 (12%)

Unknown

41 (8%)

41 (9%)

0 (0%)

Symptoms present

Voiding dysfunction

336 (68%)

318 (70%)

18 (44%)

0.0005

Dyspareunia

280 (56%)

251 (55%)

29 (71%)

0.054

Pain

276 (56%)

252 (55%)

24 (59%)

0.70

Stress urinary incontinence

211 (43%)

192 (42%)

19 (46%)

0.62

Urgency urinary incontinence

261 (53%)

241 (53%)

20 (49%)

0.60

Mixed urinary incontinence

203 (41%)

189 (42%)

14 (34%)

0.35

Urinary tract infections

284 (57%)

267 (59%)

17 (41%)

0.033